---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-21-013611"
form_type: "8-K"
ticker: "TDOC"
cik: "0001477449"
company_name: "Teladoc Health, Inc."
filed_at: "2021-10-27T23:59:59+00:00"
generated_at: "2026-06-28T17:25:36.315165+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Teladoc Q3 revenue up 81% YoY to $522M; updates FY2021 revenue outlook to $2.015-$2.025B

## Summary
- Net loss of $84.3M ($0.53 per share) vs $35.9M loss ($0.43) in Q3 2020.
- Adjusted EBITDA rose to $67.4M from $39.5M; total visits 3.9M (+37% YoY).
- U.S. paid membership grew to 52.5M (+2% YoY); chronic care enrollment 0.725M.
- New agreements with CVS Health and Centene for Primary360 primary care model.
- 2021 full-year revenue outlook raised to $2.015B-$2.025B.

## SEC filing metadata
- accession: 0001558370-21-013611
- form_type: 8-K
- ticker: TDOC
- cik: 0001477449
- company_name: Teladoc Health, Inc.
- filed_at: 2021-10-27T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1477449/000155837021013611/0001558370-21-013611-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1477449/000155837021013611/tdoc-20211027x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-21-013611
- JSON: https://secwatch.observer/filing/0001558370-21-013611.json
- Plain text: https://secwatch.observer/filing/0001558370-21-013611.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.